| Autor: |
NGUYEN, L. C., LUU, D. T. M., DOAN, H. T. N., NGUYEN, N. M., NGUYEN, H. T. T., PHAM, T. T., PHAM, N. B., LE, T. P., NGUYEN, T. T., NGUYEN, H. V. |
| Zdroj: |
European Review for Medical & Pharmacological Sciences; Dec2024, Vol. 28 Issue 24, p4701-4711, 11p |
| Abstrakt: |
OBJECTIVE: Hepatocellular carcinoma (HCC) is a significant cause of morbidity and mortality worldwide. This study aims to comprehensively evaluate the prognostic factors influencing survival in patients diagnosed with HCC. PATIENTS AND METHODS: This is a cross-sectional study aimed at identifying prognostic factors in HCC using Cox regression and Kaplan-Meier analysis. A cohort of 364 predominantly male HCC patients with a mean age of 61.6 ± 10.9 years was analyzed. RESULTS: Significant risk factors for mortality included HCV infection, alcoholism, elevated alpha- fetoprotein (AFP) and protein induced by vitamin K absence or antagonist-II (PIVKA) II levels, and a Child-Pugh score of 8. HCV-positive patients had a hazard ratio (HR) of 2.25. Average survival time was 32.99 ± 31.64 months, with 1, 2, and 3-year survival rates of 73.6%, 44.5%, and 31.3%, respectively. Patients with PIVKA-II levels ≤ 125 mAU/mL had a significantly higher 50% chance of surviving 42 months. Patients with the Barcelona clinic liver cancer (BCLC) stage B1 displayed a higher survival rate, except at the 24-month time point, with BCLC A and B1 groups showing survival rates exceeding 80% in the first year. CONCLUSIONS: T he fi ndings p rovide v aluable insights into the prognostic implications and risk stratification in HCC, facilitating personalized treatment decisions and potentially improving patient outcomes. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
